First slide

Perigord Premedia build platform for global growth with significant investment from BDO Development Capital Fund

16th February 2016

Perigord Premedia, a leader in the European life science packaging artwork management sector, today announced it has secured a significant development capital investment from the BDO Development Capital Fund to accelerate the company’s global expansion. With the life sciences sector now facing post patent cliff complexities (including unprecedented M&A activity, generic drug proliferation and product serialisation to combat counterfeiting) the pharma packaging sector will witness significant growth in the coming 5 year period.

Andrew Bourg (left), Investment Director, Development Capital, Sinead Heaney, Investment Director, Development Capital, Alan Leamy (right), CEO, Perigord Premedia

Employing over 100 people, Perigord is aiming to lead new developments in the sector. From its base in Dublin, which services the European market, Perigord plans to upgrade and open the new hubs in America, Asia and Latin America. This world-wide footprint will facilitate the creation of a global platform to service the life sciences sector and deliver true global solutions.

The funding for Perigord was secured from the BDO Development Capital Fund, a €75 million fund supported by Enterprise Ireland, Bank of Ireland and leading Irish Corporates CRH, Glanbia and Glen Dimplex. The Fund invests development and growth capital in ambitious companies to support their export growth plans. The funding will be used to build out Perigord’s global network and respond to existing demand to provide artwork solutions under global supply agreements.

Perigord has a clear plan to realise its ambition to globalise the company and achieve a dominant market share in the highly regulated sector in which it operates. Competing against multinational competitors, Perigord has successfully built strong relationships with many of the world’s leading global pharmaceutical businesses and the company’s sole focus on the pharma and life sciences industry has enabled it to achieve a compelling competitive market position.

Speaking about the company’s plans, Perigord CEO, Alan Leamy said:

“This investment from the BDO Development Capital Fund will enable us to build on the success achieved to date which is thanks to both our team of highly talented & committed people in Perigord and also the external support of Enterprise Ireland. We look forward to working with our new partners in Development Capital to increase our global scale and service the global life sciences sector as it goes through significant changes in the coming 5 year period.

We have a proven track record with some of the world’s leading pharma companies and we can now build on our European success with expansion right across the world.”

Also speaking was Sinead Heaney, Investment Director, Development Capital, who said:

“the BDO Development Capital Fund supports businesses which demonstrate the ambition, capability and strategy to deliver global expansion and achieve market leading positions. Perigord has all these qualities and we look forward to our partnership to assist them achieve their international expansion plans.”

Helen Ryan, former CEO of Creganna who is an Advisory Panel Member of the BDO Development Capital Fund also commented

“Perigord is an excellent example of the type of company the fund is seeking to support. The life science sector is experiencing significant growth and we look forward to working with Perigord to unlock this growth potential by assisting the company to build a truly global network.”

Development Capital Fund IrelandBACK TO ALL NEWS




Development Capital
Block 3,
Miesian Plaza,
Lower Baggot Street,
Dublin 2